NJ Attorney General Subpoenas Amgen

0

0

Grassley Eyes Amgen's Enbrel Marketing

Over the past month, we wrote that two former Amgen sales reps are suing the biotech for being forced to improperly promote Enbrel, which is used to treat psoriasis.

0

0

Male Birth Control Pill Stops Sperm in Brain

t's been almost ten years since Pfizer brought Viagra to the market. Now, researchers are working to crack the code on what could be another sexual health miracle: a male birth control pill.

0

0

Amgen Spends Big Protesting Curbs On Anemia Drugs

Nearly a million cancer and dialysis patients turn to Amgen Inc. for essential medicines every year. Now, Amgen is turning to its patients for some medicine of its own.

0

0

Better Blood Vessels

Researchers have developed artificial blood vessels that are derived from human cells but appear to have long shelf lives and are unlikely to provoke an immune response.

0

0

Label for Anemia Drugs Likely Won't Help Sales

The Food and Drug Administration toughened safety warnings on blockbuster anemia drugs, in a move that looked unlikely to help drug makers in their quest to liberalize Medicare payments for the medicines.

0

0

Centocor drug marks milestone

Centocor Inc. said Tuesday its flagship product Remicade, best known as a treatment for rheumatoid arthritis, has become the first anti-TNF biologic therapy to treat 1 million patients worldwide.

0

0

High-Fat Diet Can Disrupt Body's Clock

TUESDAY, Nov. 6 (HealthDay News) -- There's more bad news about a high-fat diet -- it disrupts the body's 24-hour internal (circadian) clock, which regulates sleeping, waking, eating, as well as the daily rhythms of many metabolic functions, U.S. researchers say.

0

0

Is There a Heart Attack In Your Future?

What are the chances that you will get heart disease, or Alzheimer's? Or that you'll get fat? New genetic tests will soon be available to offer people answers to these questions and more, assessing their risk for a range of conditions based on a sample of saliva.

0

0

Researchers detail cancer DNA damage

An international team led by a Boston researcher yesterday unveiled the most detailed look ever at the genetic ravages inside a lung tumor, finding at least one target for drug research and laying the foundation for an ambitious - and controversial - federal effort to identify al …

0

0

Drug Drought Deepens as FDA Approvals Lag

The malaise in Big Pharma is deepening, as 2007 shapes up as one of the slowest in years for new drugs.

0

0

Alzheimer's cold sore virus link

Alzheimer's cold sore virus link Cold sore The cold sore virus has been linked to Alzheimer's disease Evidence is building that the cold sore virus may be linked to Alzheimer's disease, an expert says.

1

0

Memo Finds FDA Limited In Foreign-Firm Oversight

WASHINGTON -- The Food and Drug Administration has shrinking resources devoted to inspection of foreign drug makers, limiting its oversight as pharmaceutical imports from China and India rise sharply, according to congressional investigators.

0

0

New wave of job cuts hits health care

y Bill Berkrot - Analysis NEW YORK (Reuters) - A lack of significant new drugs and products, declining sales of lucrative flagship franchises and fierce competition have set off a wave of "restructuring" moves among the biggest names in health care.

0

0

Participants Left Uninformed in Some Halted Medical Trials

When Congress passed a bill last month requiring makers of drugs and medical devices to disclose the results of clinical trials for all approved products, advocates of greater study disclosure applauded the move. But a provision that would have mandated disclosures for another g …

0

0

New gene therapy brings hope to cancer patients

A RADICAL plan to genetically modify the bone marrow of cancer patients to reduce the side-effects of chemotherapy is a step closer to reality at the Children's Hospital at Westmead.

0

0

Brain's 'Reward Chemical' May Help Spur Obesity

THURSDAY, Oct. 25 (HealthDay News) -- A new study provides more evidence that dopamine -- a brain chemical associated with reward, pleasure, movement and motivation -- plays a role in obesity.

0

0

Drug-craving region of brain identified

SANTIAGO - Chilean scientists have made a discovery in the brains of rats that they say may help treat drug addiction and ease the side effects of some medications.

0

0

Medicare medical chief sees no new ESA-drug evidence

WASHINGTON, Oct 24 (Reuters) - Medicare, under fire for restricting payments for anemia drugs sold by Amgen Inc (AMGN.O: Quote, Profile, Research) and Johnson & Johnson (JNJ.N: Quote, Profile, Research), has received no new evidence to support reversing the policy, a top official …

0

0

Amgen Wins Patent Battle Over Roche's Anemia Drug

Amgen won a decisive victory yesterday in a closely watched patent infringement lawsuit against Roche. The outcome could help protect Amgen's multibillion dollar anemia drug franchise in this country by blocking Roche's plan to introduce a competing medicine.

0

0

Spotting Breast Cancer Sooner

Harvard University researchers have developed an imaging contrast agent that targets a compound found in cancerous breast tissue.

0

0

Glaxo Sues US Patent Office Over New Rules

The drugmaker is upset about new rules going into effect on Nov. 1 concerning continuating patent applications.

0

0

And The Best BioPharma Employer Is…

Boehringer-Ingelheim. That's right, a new survey in Science magazine determined that the European drugmaker scored best on nearly two dozen important criteria and, as a result, switched places with Genentech in the annual ranking.

0

0

Pharmalot » Pharmalot… Pharmalittle… Good Morning

Novartis won European Union approval for Aclasta, the first once-a-year treatment for osteoporosis in postmenopausal women. The med, which is given as a 15-minute infusion, was cleared for all 27 EU member states, as well as Norway and Iceland.

0

0

Osteoporosis Drugs Fosamax, Reclast Get Safety Review

Merck & Co.'s Fosamax, Novartis AG's Reclast and similar osteoporosis drugs are being reviewed by U.S. regulators for a possible link to irregular heart rhythm.

0

0